Arbutus shareholders approve 2026 omnibus equity plan authorizing 16.3M shares

Arbutus Biopharma Corp

Shareholders elected all five director nominees: Androski, Beardsley, Bishop, Gline, Sawhney.
2026 Omnibus Share and Incentive Plan approved (138.9M for, 7.4M against); replaces 2011 and 2016 plans.
Plan authorizes 16,300,000 common shares for issuance as options, SARs, restricted shares, etc.
Non-binding advisory vote on executive compensation passed (137.6M for, 8.3M against).
Ernst & Young LLP ratified as independent auditor for FY 2026 (164.4M for, 2.1M against).

item 5.02 item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001447028-26-000024
form_type: 8-K
ticker: ABUS
cik: 0001447028
company_name: Arbutus Biopharma Corp
filed_at: 2026-05-27T20:01:33+00:00
discovered_at: 2026-05-27T20:03:00.329169+00:00
generated_at: 2026-05-27T20:06:45.306401+00:00
sec_items: ["5.02", "5.07", "9.01"]
event_type: other
sentiment: neutral
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001447028-26-000024
json_url: https://secwatch.observer/filing/0001447028-26-000024.json
markdown_url: https://secwatch.observer/filing/0001447028-26-000024.md
text_url: https://secwatch.observer/filing/0001447028-26-000024.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1447028/000144702826000024/0001447028-26-000024-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1447028/000144702826000024/abus-20260526.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

ONDS

Ondas shareholders approve increase in authorized shares to 1.2B and stock plan pool to 81M shares

Ondas Inc. May 28, 2026, 4:09 PM ET other Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other similar materiality

Filing page SEC filing

FLUT

Flutter shareholders approve 7 of 8 AGM proposals; preferred share amendment fails

Flutter Entertainment plc May 29, 2026, 5:34 PM ET other Items 5.03, 5.07, 7.01, 9.01

same SEC item: 5.07, 9.01 same event type: other similar materiality

Filing page SEC filing

RLMD

Relmada increases authorized common shares to 200M; stockholders approve 2021 Plan amendment

RELMADA THERAPEUTICS, INC. May 28, 2026, 4:59 PM ET other Items 5.03, 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other similar materiality

Filing page SEC filing

SCYX

SCYNEXIS effects 1:8 reverse stock split; authorized shares cut to 18.75M

SCYNEXIS INC May 29, 2026, 4:01 PM ET other Items 5.03, 9.01

same SEC item: 9.01 same event type: other similar materiality

Filing page SEC filing

EDSA

Edesa Biotech shareholders approve equity plan amendment adding 750K shares

Edesa Biotech, Inc. May 29, 2026, 4:15 PM ET other Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other

Filing page SEC filing

HAFC

Director Gideon Yu resigns from Hanmi board; stockholders approve 2026 ESPP

HANMI FINANCIAL CORP May 27, 2026, 6:15 PM ET other Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other

Filing page SEC filing

PFIS

Shareholders approve increase in equity plan to 300,000 shares at annual meeting

PEOPLES FINANCIAL SERVICES CORP. May 27, 2026, 8:50 AM ET other Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other

Filing page SEC filing

NRGV

Energy Vault shareholders elect three Class II directors and ratify BDO USA as auditor

Energy Vault Holdings, Inc. June 1, 2026, 11:36 AM ET other Items 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other

Filing page SEC filing

Source: SEC EDGAR

accession 0001447028-26-000024

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.